CN Stock MarketDetailed Quotes

688193 Shanghai Rendu Biotechnology

Watchlist

25.33
-0.50-1.94%

Trading Jul 4 10:00 CST

1.01BMarket Cap55.19P/E (TTM)

Shanghai Rendu Biotechnology Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

(Q9)Sep 30, 2022

(Q6)Jun 30, 2022

(Q3)Mar 31, 2022

(FY)Dec 31, 2021

Assets

Current assets

Money funds

115.90%589.91M

103.91%609.57M

-5.86%681.83M

-65.86%288.9M

-68.76%273.24M

51.02%298.93M

--724.29M

388.10%846.2M

--874.76M

15.10%197.94M

Transactional financial assets

-92.73%40.02M

-90.54%50.21M

18.77%130.64M

--521.63M

--550.29M

--530.98M

--110M

----

Notes receivable and accounts receivable

-21.18%69.7M

-26.51%77.07M

-19.30%81.43M

-12.85%86.29M

13.56%88.43M

89.56%104.86M

--100.9M

133.12%99.01M

--77.88M

41.28%55.32M

-Notes receivable

--100K

--259.95K

----

--180K

----

-Accounts receivable

-21.29%69.6M

-26.76%76.81M

-19.15%81.43M

-12.69%86.29M

13.82%88.43M

89.56%104.86M

--100.72M

132.69%98.83M

--77.7M

41.28%55.32M

Other receivables (including interest and dividends)

-42.99%957.67K

-3.88%1.1M

30.85%1.59M

229.01%1.2M

135.66%1.68M

-70.48%1.15M

--1.21M

-83.40%365.94K

--712.85K

122.22%3.88M

-Accrued interest receivable

----

--300.46K

--24.45K

----

-Other receivable

----

-3.88%1.1M

----

222.32%1.18M

----

-70.48%1.15M

----

-83.40%365.94K

----

122.22%3.88M

Advance payment

61.35%3.54M

-36.72%2.64M

-38.57%3.09M

-68.37%2.48M

-74.10%2.19M

-21.29%4.17M

--5.03M

173.35%7.85M

--8.46M

581.13%5.3M

Inventories

-14.23%27.03M

1.07%28.6M

10.62%31.17M

17.63%31.15M

57.13%31.51M

45.94%28.29M

--28.18M

10.14%26.48M

--20.05M

18.59%19.39M

Receivable financing

124.87%775.79K

103.16%532.68K

--538.2K

--96.6K

--345K

45.67%262.2K

----

--180K

Other current assets

3,747.60%155.29M

3,188.94%129.43M

-32.36%3.72M

-32.07%4.26M

725.12%4.04M

642.81%3.94M

--5.5M

323.45%6.27M

--489.14K

28.45%529.79K

Total current assets

-6.78%887.22M

-7.55%899.14M

-4.22%934.01M

-5.09%936.01M

-3.12%951.72M

244.23%972.58M

--975.12M

300.18%986.17M

--982.35M

22.62%282.54M

Non Current assets

Fixed assets

----

-5.94%85.8M

----

-0.99%87.6M

----

9.43%91.21M

----

15.91%88.48M

----

58.13%83.35M

Intangible assets

-33.55%401.57K

-32.06%449.89K

-31.31%488.7K

7.30%546.52K

9.26%604.33K

10.92%662.15K

--711.5K

-1.59%509.32K

--553.14K

14.88%596.95K

Long deferred expense

126.02%7.81M

122.63%8.3M

82.45%7.51M

131.94%7.68M

-4.36%3.46M

-4.86%3.73M

--4.12M

152.73%3.31M

--3.62M

461.27%3.92M

Deferred tax assets

14.99%13.34M

34.51%12.96M

154.71%12.69M

167.21%12.33M

198.59%11.6M

198.33%9.63M

--4.98M

21.92%4.62M

--3.88M

-47.49%3.23M

Usufruct assets

-30.86%6.23M

-28.65%6.92M

-9.03%7.62M

144.08%8.3M

134.15%9.01M

126.11%9.7M

--8.37M

-34.31%3.4M

--3.85M

--4.29M

Other non current assets

2,080.89%41.21M

3,314.34%41.15M

73.84%549.6K

-28.29%791.72K

0.37%1.89M

76.59%1.21M

--316.16K

83.34%1.1M

--1.88M

-64.25%682.5K

Adjustment items of non current assets

----

--0.01

----

Total non current assets

33.97%153.61M

33.95%155.57M

2.05%113.71M

15.62%117.26M

13.07%114.66M

20.89%116.14M

--111.43M

15.61%101.42M

--101.4M

19.53%96.07M

Total assets

-2.40%1.04B

-3.12%1.05B

-3.57%1.05B

-3.16%1.05B

-1.60%1.07B

187.56%1.09B

206.34%1.09B

225.47%1.09B

--1.08B

21.82%378.61M

Liabilities

Current liabilities

Notes payable and accounts payable

7.44%3.91M

-64.03%4.09M

-44.09%5.58M

-71.42%5.82M

-78.26%3.63M

15.67%11.38M

--9.98M

172.18%20.37M

--16.72M

23.58%9.84M

-Accounts payable

7.44%3.91M

-64.03%4.09M

-44.09%5.58M

-71.42%5.82M

-78.26%3.63M

15.67%11.38M

--9.98M

172.18%20.37M

--16.72M

23.58%9.84M

Contract liabilities

-39.97%3.99M

-23.91%5.58M

-44.52%4.41M

-33.30%4.51M

-21.99%6.65M

-20.50%7.33M

--7.95M

-33.12%6.76M

--8.53M

-36.19%9.22M

Salaries payable

-23.49%8.34M

-24.33%12.89M

-22.65%9.65M

-12.34%10.27M

0.37%10.91M

27.54%17.04M

--12.47M

87.28%11.71M

--10.86M

-18.33%13.36M

Taxs payable

42.27%1.79M

-12.75%1.55M

-79.72%1.12M

-77.94%928.32K

-81.42%1.26M

-35.87%1.77M

--5.53M

251.73%4.21M

--6.79M

-48.17%2.77M

Other payable (including interest and dividends)

-5.83%51.88M

-7.11%51.28M

-18.75%43.9M

-4.20%49.79M

0.31%55.09M

89.82%55.2M

--54.03M

75.55%51.97M

--54.92M

1.31%29.08M

-Other payable

----

-7.11%51.28M

----

-4.20%49.79M

----

89.82%55.2M

----

75.55%51.97M

----

1.31%29.08M

Non current liabilities due within one year

14.78%2.5M

12.48%2.93M

-64.27%683.71K

13.67%1.99M

36.74%2.18M

38.68%2.6M

--1.91M

62.99%1.75M

--1.59M

--1.88M

Other current liabilities

-11.35%147.41K

-5.28%131.79K

--173.17K

-58.80%141.94K

-67.61%166.28K

-17.71%139.14K

----

-49.06%344.48K

--513.34K

-59.97%169.08K

Total current liabilities

-9.17%72.56M

-17.82%78.45M

-28.69%65.52M

-24.37%73.44M

-20.05%79.89M

43.97%95.46M

--91.88M

72.22%97.11M

--99.93M

-13.97%66.31M

Current liabilities

Estimate liabilities

----

-74.14%11.8K

--4.67K

-82.43%25.79K

-82.11%42.28K

-81.05%45.63K

----

-78.22%146.82K

--236.38K

-64.63%240.73K

Deferred tax liabilities

----

--1.2M

--1.35M

--1.34M

--1.72M

----

Long term deferred income

-63.30%8.32M

-57.55%9.42M

2.09%22.66M

0.00%22.2M

--22.2M

4.23%22.2M

--22.2M

23.33%22.2M

Lease liabilities

-42.30%3.88M

-48.28%4.09M

13.39%7.01M

223.77%6.01M

230.19%6.72M

274.34%7.91M

--6.18M

-48.36%1.86M

--2.04M

--2.11M

Total non current liabilities

-60.36%12.2M

-57.56%13.53M

8.79%30.88M

24.13%30.04M

25.71%30.76M

29.82%31.87M

--28.38M

-5.34%24.2M

--24.47M

31.44%24.55M

Total liabilities

-23.40%84.76M

-27.77%91.97M

-19.84%96.4M

-14.69%103.49M

-11.05%110.65M

40.15%127.34M

46.15%120.26M

48.02%121.31M

--124.4M

-5.11%90.86M

Shareholders equity

Paid-in capital

0.00%40M

33.33%40M

--40M

33.33%40M

--40M

0.00%30M

Capital reserve funds

-0.32%774.96M

-0.33%773.7M

-0.14%778.3M

-0.43%778.3M

-0.36%777.47M

473.13%776.23M

--779.37M

494.92%781.64M

--780.25M

6.48%135.44M

Surplus reserve funds

13.60%12.92M

0.00%11.38M

--11.38M

89.52%11.38M

--11.38M

89.52%11.38M

Retained profit

9.20%140.17M

1.27%136.46M

-10.18%121.41M

-10.34%119.56M

0.10%128.36M

20.94%134.75M

--135.18M

56.48%133.34M

--128.23M

113.55%111.42M

Less:Treasury stock

--11.71M

----

Other composite income

81.17%-279.93K

64.06%-348.6K

-34.53%232.78K

722.06%544.82K

-191.95%-1.49M

-99.34%-969.95K

--355.56K

77.83%-87.58K

---509.2K

-45.11%-486.58K

Shareholders equity without minority interests

0.04%956.07M

0.14%962.74M

-1.55%951.32M

-1.71%949.78M

-0.38%955.72M

234.11%961.38M

254.73%966.28M

283.13%966.27M

--959.35M

33.82%287.75M

Total shareholder equity

0.04%956.07M

0.14%962.74M

-1.55%951.32M

-1.71%949.78M

-0.38%955.72M

234.11%961.38M

254.73%966.28M

283.13%966.27M

--959.35M

33.82%287.75M

Total liabilityies and equity

-2.40%1.04B

-3.12%1.05B

-3.57%1.05B

-3.16%1.05B

-1.60%1.07B

187.56%1.09B

206.34%1.09B

225.47%1.09B

--1.08B

21.82%378.61M

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Lixin Certified Public Accountants (Special General Partnership)

	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022	(Q9)Sep 30, 2022	(Q6)Jun 30, 2022	(Q3)Mar 31, 2022	(FY)Dec 31, 2021
Assets
Current assets
Money funds	115.90%589.91M	103.91%609.57M	-5.86%681.83M	-65.86%288.9M	-68.76%273.24M	51.02%298.93M	--724.29M	388.10%846.2M	--874.76M	15.10%197.94M
Transactional financial assets	-92.73%40.02M	-90.54%50.21M	18.77%130.64M	--521.63M	--550.29M	--530.98M	--110M	----	----	----
Notes receivable and accounts receivable	-21.18%69.7M	-26.51%77.07M	-19.30%81.43M	-12.85%86.29M	13.56%88.43M	89.56%104.86M	--100.9M	133.12%99.01M	--77.88M	41.28%55.32M
-Notes receivable	--100K	--259.95K	----	----	----	----	--180K	--180K	--180K	----
-Accounts receivable	-21.29%69.6M	-26.76%76.81M	-19.15%81.43M	-12.69%86.29M	13.82%88.43M	89.56%104.86M	--100.72M	132.69%98.83M	--77.7M	41.28%55.32M
Other receivables (including interest and dividends)	-42.99%957.67K	-3.88%1.1M	30.85%1.59M	229.01%1.2M	135.66%1.68M	-70.48%1.15M	--1.21M	-83.40%365.94K	--712.85K	122.22%3.88M
-Accrued interest receivable	----	----	--300.46K	--24.45K	----	----	----	----	----	----
-Other receivable	----	-3.88%1.1M	----	222.32%1.18M	----	-70.48%1.15M	----	-83.40%365.94K	----	122.22%3.88M
Advance payment	61.35%3.54M	-36.72%2.64M	-38.57%3.09M	-68.37%2.48M	-74.10%2.19M	-21.29%4.17M	--5.03M	173.35%7.85M	--8.46M	581.13%5.3M
Inventories	-14.23%27.03M	1.07%28.6M	10.62%31.17M	17.63%31.15M	57.13%31.51M	45.94%28.29M	--28.18M	10.14%26.48M	--20.05M	18.59%19.39M
Receivable financing	124.87%775.79K	103.16%532.68K	--538.2K	--96.6K	--345K	45.67%262.2K	----	----	----	--180K
Other current assets	3,747.60%155.29M	3,188.94%129.43M	-32.36%3.72M	-32.07%4.26M	725.12%4.04M	642.81%3.94M	--5.5M	323.45%6.27M	--489.14K	28.45%529.79K
Total current assets	-6.78%887.22M	-7.55%899.14M	-4.22%934.01M	-5.09%936.01M	-3.12%951.72M	244.23%972.58M	--975.12M	300.18%986.17M	--982.35M	22.62%282.54M
Non Current assets
Fixed assets	----	-5.94%85.8M	----	-0.99%87.6M	----	9.43%91.21M	----	15.91%88.48M	----	58.13%83.35M
Intangible assets	-33.55%401.57K	-32.06%449.89K	-31.31%488.7K	7.30%546.52K	9.26%604.33K	10.92%662.15K	--711.5K	-1.59%509.32K	--553.14K	14.88%596.95K
Long deferred expense	126.02%7.81M	122.63%8.3M	82.45%7.51M	131.94%7.68M	-4.36%3.46M	-4.86%3.73M	--4.12M	152.73%3.31M	--3.62M	461.27%3.92M
Deferred tax assets	14.99%13.34M	34.51%12.96M	154.71%12.69M	167.21%12.33M	198.59%11.6M	198.33%9.63M	--4.98M	21.92%4.62M	--3.88M	-47.49%3.23M
Usufruct assets	-30.86%6.23M	-28.65%6.92M	-9.03%7.62M	144.08%8.3M	134.15%9.01M	126.11%9.7M	--8.37M	-34.31%3.4M	--3.85M	--4.29M
Other non current assets	2,080.89%41.21M	3,314.34%41.15M	73.84%549.6K	-28.29%791.72K	0.37%1.89M	76.59%1.21M	--316.16K	83.34%1.1M	--1.88M	-64.25%682.5K
Adjustment items of non current assets	----	----	--0.01	--0.01	----	----	----	----	----	----
Total non current assets	33.97%153.61M	33.95%155.57M	2.05%113.71M	15.62%117.26M	13.07%114.66M	20.89%116.14M	--111.43M	15.61%101.42M	--101.4M	19.53%96.07M
Total assets	-2.40%1.04B	-3.12%1.05B	-3.57%1.05B	-3.16%1.05B	-1.60%1.07B	187.56%1.09B	206.34%1.09B	225.47%1.09B	--1.08B	21.82%378.61M
Liabilities
Current liabilities
Notes payable and accounts payable	7.44%3.91M	-64.03%4.09M	-44.09%5.58M	-71.42%5.82M	-78.26%3.63M	15.67%11.38M	--9.98M	172.18%20.37M	--16.72M	23.58%9.84M
-Accounts payable	7.44%3.91M	-64.03%4.09M	-44.09%5.58M	-71.42%5.82M	-78.26%3.63M	15.67%11.38M	--9.98M	172.18%20.37M	--16.72M	23.58%9.84M
Contract liabilities	-39.97%3.99M	-23.91%5.58M	-44.52%4.41M	-33.30%4.51M	-21.99%6.65M	-20.50%7.33M	--7.95M	-33.12%6.76M	--8.53M	-36.19%9.22M
Salaries payable	-23.49%8.34M	-24.33%12.89M	-22.65%9.65M	-12.34%10.27M	0.37%10.91M	27.54%17.04M	--12.47M	87.28%11.71M	--10.86M	-18.33%13.36M
Taxs payable	42.27%1.79M	-12.75%1.55M	-79.72%1.12M	-77.94%928.32K	-81.42%1.26M	-35.87%1.77M	--5.53M	251.73%4.21M	--6.79M	-48.17%2.77M
Other payable (including interest and dividends)	-5.83%51.88M	-7.11%51.28M	-18.75%43.9M	-4.20%49.79M	0.31%55.09M	89.82%55.2M	--54.03M	75.55%51.97M	--54.92M	1.31%29.08M
-Other payable	----	-7.11%51.28M	----	-4.20%49.79M	----	89.82%55.2M	----	75.55%51.97M	----	1.31%29.08M
Non current liabilities due within one year	14.78%2.5M	12.48%2.93M	-64.27%683.71K	13.67%1.99M	36.74%2.18M	38.68%2.6M	--1.91M	62.99%1.75M	--1.59M	--1.88M
Other current liabilities	-11.35%147.41K	-5.28%131.79K	--173.17K	-58.80%141.94K	-67.61%166.28K	-17.71%139.14K	----	-49.06%344.48K	--513.34K	-59.97%169.08K
Total current liabilities	-9.17%72.56M	-17.82%78.45M	-28.69%65.52M	-24.37%73.44M	-20.05%79.89M	43.97%95.46M	--91.88M	72.22%97.11M	--99.93M	-13.97%66.31M
Current liabilities
Estimate liabilities	----	-74.14%11.8K	--4.67K	-82.43%25.79K	-82.11%42.28K	-81.05%45.63K	----	-78.22%146.82K	--236.38K	-64.63%240.73K
Deferred tax liabilities	----	----	--1.2M	--1.35M	--1.34M	--1.72M	----	----	----	----
Long term deferred income	-63.30%8.32M	-57.55%9.42M	2.09%22.66M	2.09%22.66M	2.09%22.66M	0.00%22.2M	--22.2M	4.23%22.2M	--22.2M	23.33%22.2M
Lease liabilities	-42.30%3.88M	-48.28%4.09M	13.39%7.01M	223.77%6.01M	230.19%6.72M	274.34%7.91M	--6.18M	-48.36%1.86M	--2.04M	--2.11M
Total non current liabilities	-60.36%12.2M	-57.56%13.53M	8.79%30.88M	24.13%30.04M	25.71%30.76M	29.82%31.87M	--28.38M	-5.34%24.2M	--24.47M	31.44%24.55M
Total liabilities	-23.40%84.76M	-27.77%91.97M	-19.84%96.4M	-14.69%103.49M	-11.05%110.65M	40.15%127.34M	46.15%120.26M	48.02%121.31M	--124.4M	-5.11%90.86M
Shareholders equity
Paid-in capital	0.00%40M	0.00%40M	0.00%40M	0.00%40M	0.00%40M	33.33%40M	--40M	33.33%40M	--40M	0.00%30M
Capital reserve funds	-0.32%774.96M	-0.33%773.7M	-0.14%778.3M	-0.43%778.3M	-0.36%777.47M	473.13%776.23M	--779.37M	494.92%781.64M	--780.25M	6.48%135.44M
Surplus reserve funds	13.60%12.92M	13.60%12.92M	0.00%11.38M	0.00%11.38M	0.00%11.38M	0.00%11.38M	--11.38M	89.52%11.38M	--11.38M	89.52%11.38M
Retained profit	9.20%140.17M	1.27%136.46M	-10.18%121.41M	-10.34%119.56M	0.10%128.36M	20.94%134.75M	--135.18M	56.48%133.34M	--128.23M	113.55%111.42M
Less:Treasury stock	--11.71M	----	----	----	----	----	----	----	----	----
Other composite income	81.17%-279.93K	64.06%-348.6K	-34.53%232.78K	722.06%544.82K	-191.95%-1.49M	-99.34%-969.95K	--355.56K	77.83%-87.58K	---509.2K	-45.11%-486.58K
Shareholders equity without minority interests	0.04%956.07M	0.14%962.74M	-1.55%951.32M	-1.71%949.78M	-0.38%955.72M	234.11%961.38M	254.73%966.28M	283.13%966.27M	--959.35M	33.82%287.75M
Total shareholder equity	0.04%956.07M	0.14%962.74M	-1.55%951.32M	-1.71%949.78M	-0.38%955.72M	234.11%961.38M	254.73%966.28M	283.13%966.27M	--959.35M	33.82%287.75M
Total liabilityies and equity	-2.40%1.04B	-3.12%1.05B	-3.57%1.05B	-3.16%1.05B	-1.60%1.07B	187.56%1.09B	206.34%1.09B	225.47%1.09B	--1.08B	21.82%378.61M
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	Unqualified opinion	--	--	--	--	--	--	--	--
Auditor	--	Lixin Certified Public Accountants (Special General Partnership)	--	--	--	Lixin Certified Public Accountants (Special General Partnership)	--	--	--	Lixin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

688193 Shanghai Rendu Biotechnology

Shanghai Rendu Biotechnology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Analysis

Analyst Rating

Price Target